Immune response of mice to Echinococcus multilocularis infection after therapy with amphotericin B colloidal dispersion

Helminthologia

Volumn 44, Issue 2, 2007, Pages 47-56

  Porubcova J ^a   Dvoroznakova E ^a   Sevcikova Z ^b  

^a PARASITOLOGICAL INSTITUTE   (Slovakia)

^b UNIVERSITY OF VETERINARY MEDICINE   (Slovakia)

Author keywords

Amphotericin B; Echinococcus multilocularis; IFN ; IL 5; Mice; Superoxide anion; T and B lymphocytes

Indexed keywords

ECHINOCOCCUS; ECHINOCOCCUS MULTILOCULARIS; MUS;

EID: 34247568518     PISSN: 04406605     EISSN: None     Source Type: Journal    
DOI: 10.2478/s11687-007-0003-y     Document Type: Article

References (55)

1. ABBAS, A. K., MURPHY, K. M., SHER, A. (1996): Functional diversity of helper T lymphocytes. Nature, 383: 787-793
2. ABU-SALAH, K. M. (1996): Amphotericin B: an update. Brit. J. Biomed. Sci., 53: 122-133
3. AMMANN, R. W., ECKERT, J. (1996): Cestodes: Echinococcus. Gastroenter. Clin. North Am., 25: 655-689
4. BOROŠKOVÁ, Z., DVORŽŇÁ KOVÁ, E., ŠEVČÍKOVÁ, Z. (2003): Cellular immune reactions of mice with alveolar echinococcosis after albendazole therapy. Helminthologia, 40: 187-194
5. BRAJTBURG, J., BOLARD, J. (1996): Carrier effects on biological activity of amphotericin B. Clin. Microb. Rev., 9: 512-531
6. BRAJTBURG, J., POWDERLY, W. G., KOBAYASHI, G. S., MEDOFF, G. (1990): Amphotericin B: current understanding of mechanisms of action. Antimicrob. Agents Chemother., 34: 183-188
7. BRESSON-HADNI, S., LIANCE, A., MEYER, J. P., HOUIN, R., BRESSON, J. L., VUITTON, D. A. (1990): Cellular immunity in experimental Echinococcus multilocularis infection. II. Sequental and comparative phenotypic study of the periparasitic mononuclear cells in resistant and sensitive mice. Clin. Exp. Immunol., 82: 378-383
8. CAPECE, B. P., NAVARRO, M., ARCALIS, T., CASTELLS, G., TORTBIO, L., PEREZ, F., CARRETERO, A., RUBERTE, J., ARBOIX, M., CRISTOFOL, C. (2003): Albendazole sulphoxide enantiomers in pregnant rats' embryo concentrations and developmental toxicity. Vet. J., 165: 266-275
9. CHRISTIANSEN, K. J., BERNARD, E. M., GOLD, J. W. M., ARMSTRONG, D. (1985): Distribution and activity of amphotericin B in humans. J. Infect. Dis., 152: 1037-1043
10. CLEMENTS, J. S. JR., PEACOCK, J. E. JR. (1990): Amphotericin B revisited: reassessment of toxicity. Amer. J. Med., 88: 22-27
11. CLEMONS, K. V., SOBEL, R. A., WILLIAMS, P. L., STEVENS, D. A. (2001): Comparative toxicities and pharmacokinetics of intrathecal lipid (amphotericin B colloidal dispersion) and conventional deoxycholate formulations of amphotericin B in rabbits. Antimicrob. Agents Chemother., 45: 612-615
12. DVOROŽŇÁKOVÁ, E., HRČKOVÁ, G., BOROŠKOVÁ, Z., VELEBNÝ, S., DUBINSKÝ, P. (2004): Effect of treatment with free and liposomized albendazole on selected immunological parameters and cyst growth in mice infected with Echinococcus multilocularis. Parasitol. Int., 53: 315-325
13. EHRENFREUND-KLEINMAN, T., DOMB, A. J., JAFFE, C. L., NASEREDDIN, A., LESHEM, B., GOLENSER, J. (2005): The effect of amphotericin b derivatives on Leishmania and immune functions. J. Parasitol., 91: 158-163
14. ELLIS, D. (2002): Amphotericin B: spectrum and resistance. J. Antimicrob. Chemother., 49: 7-10
15. EMERY, I., LIANCE, M., DERIAUD, E., VUITTON, D. A., HOUIN, E., LECLERC, C. (1996): Characterization of T-cell immune responses of Echinococcus multilocularis-infected. Parasite. Immunol., 18: 463-472
16. GEGINAT, G., KRETSCHMAR, M., WALTER, S., JUNKER, D., HOF, H., NICHTERLEIN, T. (1999): Suppression of acquired immunity against Listeria monocytogenes by amphotericin B-mediated inhibition of CD8 T cell function. J. Infect. Dis., 180: 1186-1194
17. GILBERT, B. E., WYDE, P. R., WILLSON, S. Z. (1992): Aerosolized liposomal amphotericin B liposomes for treatment of pulmonary and systematic Cryptococcus neoformans infections in mice. Antimicrob. Agents Chemother., 36: 1466-1471
18. GOTTSTEIN, B., HAAG, K., WALKER, M., MATSUMOTO, J., MEJRI, N., HEMPHILL, A. (2006): Molecular survival strategies of Echinococcus multilocularis in the murine host. Parasitol. Int., 55: S45-S49
19. HANN, I. M., PRENTICE, H. G. (2001): Lipid-based amphotericin B: a review of the last 10 years of use. Int. J. Antimicrob. Agents, 17: 161-169
20. HEATH, D. D. (1995): Immunology of Echinococcus infection. In THOMPSON, R. C. A., LYMBERY, A. J. (Eds): Echinococcus and hydatid disease. CAB INTERNATIONAL, Wallingford, UK: 183-199
21. HIEMENZ, J. W., WALSH, T. J. (1996): Lipid formulations of amphotericin B: recent progress and future directions. Clin. Infect. Dis., 22: S133-S144
22. HRČKOVÁ, G., VELEBNÝ, S. (1997): Effect of praziquantel and liposome-incorporated praziquantel on peritoneal macrophage activation in mice infected with Mesocestoides corti tetrathyridia (Cestoda). Parasitology, 114: 475-482
23. INSELMANN, G., VOLKMANN A., HEIDEMANN, H. T. (2000): Comparison of the effects of liposomal amphotericin B and conventional amphotericin B on propafenone metabolism and hepatic cztochrome P.450 in rats. Antimicrob. Agents Chemother., 44:131-133
24. JANKNEGT, R., DEMARIE, S., BAKKER- WOUDENBERG, I. A., CROMMELIN D. J. (1992): Liposomal and lipid formulations of amphotericin B. Clin. Pharmacokinet., 23: 279-291
25. JOLY, V., FARINOTTI, R., SAINT-JULIEN, L., CHÉRON, M., CARBON, C., ZENI, P. (1994): In vitro renal toxicity and in vivo therapeutic efficacy in experimental murine cryptococcosis of amphotericin B (Fungizone) associated with intralipid. Antimicrob. Agents Chemother., 38: 177-183
26. KARYOTAKIS, N. C., ANAISSIE, E. J. (1994): Efficacy of escalating doses of liposomal amphotericin B (AmBisome) against hematogenous Candida lusitaniae and Candida krusei infection in neutropenic mice. Antimicrob. Agents Chemother., 38: 2660-2662
27. KILWINSKI, J., JENNE, L., JELLEN-R ITTER, A., RADLOFF, P., FLICK, W., KERN, P. (1999): T lymphocyte cytokine profile at a single cell level in alveolar echinococcosis. Cytokine, 11: 373-381
28. dull suppressor cells in spleens of mice intraperitoneally infected with E. multilocularis. J. Immunol., 147: 1659-1666
29. MANFRAS, B. J., REUTER, S., WENDLAND, T., BOEHM, B. O., KERN, P. (2004): Impeded Th1 CD4 memory T cell generation in chronic-persisting liver infection with Echinococcus multilocularis. Int. Immunol., 16: 43-50
30. MURRAY, H. W. (2005): Prevention of relapse after chemotherapy in a chronic intracellular infection: mechanisms in experimental visceral leishmaniasis. J. Immunol., 174: 4916-4923
31. PAGÉ, M., BAJAOUNI, N., CIQO- MARS, B., LEMIEUX, P. (1988): Optimization the tetrazolium based colorimetric assay for the measurement of cell number and cytotoxicity. Int. J. Immunopharmacol., 10: 785-793
32. PÉREZ-SERRANO, J., DENEGRI, G., CASADO, N., RODRÍGUEZ-CAABEIRO, F. (1997): In vivo effect of oral albendazole and albendazole sulphoxide on development of secondary Echinococcosis in mice. Int. J. Parasitol., 27: 1341-1345
33. PERSAT, F., BOUHOURS, J. F., MOJON, M., PETAVY, A. F. (1990): Analysis of the monohexosylceramide fraction of Echinococcus multilocularis metacestodes. Mol. Biochem. Parasitol., 41: 1-6
34. RAMA-INIGUEZ, S., DEA-AYUELA, M. A., SANCHEZ-BRUNETE J. A., TORRADO, J. J., ALUNDA, J. M., BOLAS-FERNANDEZ, F. (2006): Real-time reverse transcription-PCR quantification of cytokine mRNA expression in golden Syrian hamster infected with Leishmania infantum and treated with a new amphotericin B formulation. Antimicrob. Agents Chemother., 50: 1195-1201
35. RESCH, K. (1999): Cytokines. In NIJKAMP F. P., PARNHAM, M. J. (Eds): Principles of Immunopharmacology. Birghäuser Verlag, Basel, Boston, Berlin: 53-81
36. REUBEN, J. M, TANNER, C. E. (1983): Protection against experimental echinococcosis by non-specifically stimulated peritoneal cells. Parasite Immunol., 5: 61-66
37. REUTER, S., JENSEN, B., BUTTENSCHOEN, K., KRATZER, W., KERN, P. (2000): Benzimidazoles in the treatment of alveolar echinococcosis: a comparative study and review of the literature. J. Antimicrob. Chemother., 46: 451-456
38. REUTER, S., MERKLE, M., BREHM, K., KERN, P., MANFRAS, B. (2003a): Effect of amphotericin B on larval growth of Echinococcus multilocularis. Antimicrob. Agents Chemother., 47: 620-625
39. REUTER, S., BUCK, A., GREBE, O., NUSSLE-KUGELE, K., KERN, P., MANFRAS, B. J. (2003b): Salvage treatment with amphotericin B in progressive human alveolar echinococcosis. Antimicrob. Agents Chemother., 47: 3586-3591
40. RIGANO, R., PROFUMO, E., BUTTARI, B., TEGGI, A., SIRACUSANO, A. (1999): Cytokine gene expression in peripheral blood mononuclear cells (PBMC) from patients with pharmacologically treated cystic echinococcosis. Clin. Exp. Immunol., 118: 95-101
41. SAU, K., MAMBULA, S. S., LATZ, E., HENNEKE, P., GOLENBOCK, D. T., LEVITZ, S. M. (2003): The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism. J. Biol. Chem., 278: 37561-37568
42. SCHANTZ, P. M. (2002): Progress and challenges in biology, treatment and control of echinococcosis. Abstracts ICOPA X, Vancouver, Canada: 243
43. SCHINDLER, J. J., WARREN, R. P., ALLEN, S. D., JACKSON, M. K. (1993): Immunological effects of amphotericin B and liposomal amphotericin B on splenocytes from immune-normal and compromised mice. Antimicrob. Agents Chemother, 37: 2716-2721
44. SLMITSOPOULOU, M., ROILIDES, E., DOTIS, J., DALAKIOURIDOU, M., DUDKOVA, A. F., ANDREADOU, E., WALSH, T. J. (2005): Differential expression of cytokines and chemokines in human monocytes induced by lipid formulations of amphotericin B. Antimicrob. Agents Chemother., 49: 1397-1403
45. STEIN, S. H., LITTLE, J. R., LITTLE, K. D. (1987): Parallel inheritance of tissue catalase activity and immunostimulatory action of amphotericin B in inbred mouse strains. Cell. Immunol., 105: 99-109
46. STURM, D., MENZEL, J., GOTTSTEIN, B., KERN, P. (1995): Interleukin-5 is the predominant cytokine produced by peripheral blood mononuclear cells in alveolar echinococcosis. Infect. Immun., 63: 1688-1697
47. ŠOLTÝS, J., QUINN, M. T. (1999): Modulation of endotoxin- and enterotoxin-induced cytokine release by in vivo treatment with β-(1,6)-branched β-(1,3)-glucan. Infect. Immun., 67: 244-252
48. ŠOLTÝS, J., TURČEKOVÁ, E., RYCKE, DE P. H. (1999): The effect Echinococcus hydatid cyst fluid and protoscoleces on mouse peritoneal macrophages and spleen lymphocytes. Helminthologia, 36: 25-30
49. THOMPSON, R. C. A. (1995): Biology and systematics of Echinococcus. In THOMPSON, R. C. A., LYMBERY, A. J. (Eds): Echinococcus and hydatid disease. CAB INTERNATIONAL, Wallingford, UK: 1-50
50. VUITTON, D. A. (2003): The ambiguous role of immunity in Echinococcosis: protection of the host or of the parasite? Acta. Trop., 85: 119-132
51. VUITTON, D. A., ZHANG, S. L., YANG, Y., GODOT, V., BEURTON, I., MANTION, G., BRESSON-HADNI, S. (2006): Survival strategy of Echinococcus multilocularis in the human host. Parasitol. Int., 55: S51-S55
52. VUITTON, D. A. (1999): New trends in the treatment of echinococcosis. Helminthologia, 36: 167-170
53. WOLF, J. E., MASSOF, S. E. (1990): In vivo activation of macrophage oxidative burst activity by cytokines and amphotericin B. Infect. Immun., 58:1296-1300
54. YARDLEY, V., CROFT, S. L. (1999): In vitro and in vivo activity of amphotericin B-lipid formulations against experimental Trypanosoma cruzi infections. Am. J. Trop. Med. Hyg., 61: 193-197
55. ZHANG, Z., LIPMAN, J. M., DIENER, R. M., THOMAS, P. (2006): Comparative immunotoxicity evaluation of amphotericin B and ABELCET, an amphotericin B lipid complex (ABLC). Int. J. Toxicol., 25: 487-492